Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.8 USD | +4.39% |
|
-1.31% | -32.98% |
06-04 | Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses | CI |
05-09 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.98% | 1.01B | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
+10.74% | 25.92B | |
-13.50% | 26.03B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B | |
-12.61% | 10.64B |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- Sector Update: Health Care Stocks Extending Thursday Advance